Variant report
Variant | esv2762929 |
---|---|
Chromosome Location | chr11:86984276-86986505 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs12281665 | chr11:86984276-86984277 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs534211345 | chr11:86984281-86984282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs143009066 | chr11:86984346-86984347 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs111894319 | chr11:86984360-86984361 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs182045884 | chr11:86984396-86984397 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs570675365 | chr11:86984420-86984421 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs55819544 | chr11:86984439-86984440 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs568857238 | chr11:86984442-86984443 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs575408228 | chr11:86984505-86984506 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs187096501 | chr11:86984610-86984611 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs12294991 | chr11:86984624-86984625 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs190549118 | chr11:86984649-86984650 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs546604490 | chr11:86984729-86984730 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs78897740 | chr11:86984776-86984777 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs529193552 | chr11:86984827-86984828 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs182737815 | chr11:86984839-86984840 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs12295149 | chr11:86984874-86984875 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs537662313 | chr11:86984902-86984903 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs200225355 | chr11:86984925-86984926 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs369204210 | chr11:86984935-86984936 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs551553226 | chr11:86985000-86985001 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs536919844 | chr11:86985008-86985009 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs201867133 | chr11:86985042-86985043 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs34056293 | chr11:86985044-86985045 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs572919203 | chr11:86985046-86985047 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs371457229 | chr11:86985050-86985051 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs571737689 | chr11:86985055-86985056 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs185475223 | chr11:86985079-86985080 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs12290427 | chr11:86985111-86985112 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs117600408 | chr11:86985125-86985126 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs536993312 | chr11:86985146-86985147 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs556905926 | chr11:86985155-86985156 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs371744706 | chr11:86985161-86985162 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs545604040 | chr11:86985164-86985165 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs375106544 | chr11:86985196-86985197 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs115310303 | chr11:86985202-86985203 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs577700287 | chr11:86985210-86985211 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs574361620 | chr11:86985214-86985215 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs539836151 | chr11:86985245-86985246 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs12290541 | chr11:86985288-86985289 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs111460300 | chr11:86985291-86985292 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs150837980 | chr11:86985308-86985309 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs36044870 | chr11:86985327-86985328 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs67620325 | chr11:86985328-86985329 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs139316892 | chr11:86985367-86985368 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs301598 | chr11:86985408-86985409 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs531379196 | chr11:86985422-86985423 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs551582622 | chr11:86985436-86985437 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs571635799 | chr11:86985464-86985465 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs149921438 | chr11:86985488-86985489 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17157792 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 22429812 | CNVD |
Breast cancer | 21364760 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Breast cancer | 16608533 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Developmental delay | 21147756 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Attention deficit hyperactivity disorder | 22241247 | CNVD |
Breast cancer | 21958427 | CNVD |
Breast cancer | 17133270 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Obesity | 20622171 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:86969800-86995400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr11:86978000-86995200 | Weak transcription | NHDF-Ad | bronchial |
3 | chr11:86980000-86986400 | Weak transcription | Fetal Stomach | stomach |
4 | chr11:86982600-86984600 | Weak transcription | Hela-S3 | cervix |
5 | chr11:86984600-86985000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
6 | chr11:86984600-86985000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
7 | chr11:86984600-86985000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr11:86984600-86985200 | Enhancers | Hela-S3 | cervix |
9 | chr11:86984800-86985200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
10 | chr11:86984800-86985200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
11 | chr11:86984800-86985400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
12 | chr11:86985000-86992800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
13 | chr11:86985200-86990800 | Weak transcription | Hela-S3 | cervix |
14 | chr11:86986200-86986400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
15 | chr11:86986200-86986600 | Enhancers | Colon Smooth Muscle | Colon |
16 | chr11:86986400-86987000 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
17 | chr11:86986400-86987200 | Enhancers | Fetal Stomach | stomach |